| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
the numbers of cases of nms (smq code: 20000044) reported for risperidone, aripiprazole, haloperidol, olanzapine, and quetiapine were 1691, 1294, 1132, 1056, and 986, respectively. |
2024-10-01 |
2024-10-03 |
Not clear |
| Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, Wataru Wakabayashi, Keita Oura, Satoshi Nakao, Nanaka Ichihara, Yuka Nokura, Moe Yamashita, Kensuke Matsui, Hideyuki Tanaka, Mayuko Masuta, Ichiro Ieiri, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system. Heliyon. vol 9. issue 11. 2023-11-30. PMID:38034668. |
rors (95 % confidence interval) of nms for haloperidol, chlorpromazine, risperidone, and aripiprazole were 12.1 (11.1-13.3), 6.3 (5.7-7.0), 6.2 (5.8-6.6), and 4.7 (4.4-5.1), respectively. |
2023-11-30 |
2023-12-10 |
Not clear |
| Ling Deng, Zhi-Xin Qiu, Mao-Yun Wan. Risperidone-induced neuroleptic malignant syndrome: a case report. Therapeutic advances in psychopharmacology. vol 12. 2022-05-19. PMID:35586306. |
we report the case of a patient with nms induced by irregular use of antipsychotics, especially risperidone (rsp). |
2022-05-19 |
2023-08-13 |
Not clear |
| Fuminari Misawa, Yasuyuki Okumura, Yoshinori Takeuchi, Yasuo Fujii, Hiroyoshi Takeuch. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophrenia research. vol 231. 2021-07-05. PMID:33752105. |
between 42% and 62% of the nms associated with lai- and oral sgas other than lai risperidone occurred within 30 days after initiation. |
2021-07-05 |
2023-08-13 |
Not clear |
| Fuminari Misawa, Yasuyuki Okumura, Yoshinori Takeuchi, Yasuo Fujii, Hiroyoshi Takeuch. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophrenia research. vol 231. 2021-07-05. PMID:33752105. |
the proportions of mortality due to nms associated with oral risperidone/paliperidone, lai risperidone, and lai paliperidone were 8.8%, 4.2%, and 3.4%, respectively. |
2021-07-05 |
2023-08-13 |
Not clear |
| Müge Ayanoğlu, Elif Korgali, Taner Sezer, Halil Ibrahim Aydin, Fatma Müjgan Sönme. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. Brain & development. vol 42. issue 5. 2020-12-21. PMID:32173091. |
we describe the first child with guanidinoacetate methyltransferase (gamt) deficiency who developed neuroleptic malignant syndrome (nms) after the treatment of risperidone without elevated creatine kinase (ck) levels. |
2020-12-21 |
2023-08-13 |
Not clear |
| Müge Ayanoğlu, Elif Korgali, Taner Sezer, Halil Ibrahim Aydin, Fatma Müjgan Sönme. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. Brain & development. vol 42. issue 5. 2020-12-21. PMID:32173091. |
after cessation of risperidone and adding clonezepam to the supportive treatment, symptoms of nms were ameliorated. |
2020-12-21 |
2023-08-13 |
Not clear |
| Anna Maria Szota, Izabela Radajewska, Przemysław Grudzka, Aleksander Araszkiewic. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:32306929. |
neuroleptic malignant syndrome (nms) may be induced by atypical antipsychotic drugs (aapds) such as aripiprazole, olanzapine, risperidone and quetiapine, either as a single treatment or in combination with other drugs. |
2020-12-21 |
2023-08-13 |
Not clear |
| Mitsuhito Soh, Toru Hifumi, Shutaro Isokawa, Masato Shimizu, Norio Otani, Shinichi Ishimats. Neuroleptic malignant syndrome in patients with COVID-19. The American journal of emergency medicine. vol 38. issue 10. 2020-12-09. PMID:32473756. |
nms diagnosis was confirmed, and both, favipiravir and risperidone were discontinued on day 8. |
2020-12-09 |
2023-08-13 |
Not clear |
| Quintí Foguet-Boreu, Montse Coll-Negre, Montse Serra-Millàs, Miquel Cavalleria-Verdague. Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion. Clinics and practice. vol 8. issue 1. 2020-10-01. PMID:29441189. |
during her third hospital admission, symptoms of autonomic instability, hyperpyrexia, severe extrapyramidal side effects, and delirium appeared, suggesting nms due to concomitant treatment with risperidone and quetiapine, among other drugs. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ting-Ren Chen, Ying-Chang Che. Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30618887. |
here, we report a case of risperidone-associated nms in which a successful rechallenge of risperidone was observed with a positive follow-up. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ting-Ren Chen, Ying-Chang Che. Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30618887. |
on hospital day 116, nms occurred and thus we discontinued all antipsychotics including lai risperidone, then nms improved. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jong-Il Park, Tae Won Par. Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 3. 2020-09-30. PMID:31352714. |
in this case report, we present a case of nms in a child which occurred shortly after the resolution of rhabdomyolysis which was induced by low-dose risperidone. |
2020-09-30 |
2023-08-13 |
Not clear |
| Michael Esang, Sabina Goldstein, Ravina Dham. The Role of Physical Examinations in Psychiatry as Illustrated in a Case of Neuroleptic Malignant Syndrome Versus Viral Encephalitis: A Case Report and Literature Review. Cureus. vol 11. issue 6. 2020-09-30. PMID:31410323. |
he had been taking risperidone 1 mg orally every 12 hours for two months. his primary treatment team suspected neuroleptic malignant syndrome (nms), but the consulting psychiatrist detected equivocal findings on physical examination and recommended a broader differential diagnosis. |
2020-09-30 |
2023-08-13 |
Not clear |
| P Brittany Vickery, Lindsy Meadowcraft, Stephen B Vicker. Early detection of an atypical presentation of neuroleptic malignant syndrome: A case report. The mental health clinician. vol 7. issue 3. 2020-09-29. PMID:29955512. |
this article reports a case of suspected atypical nms in a patient following rapid conversion of ziprasidone to risperidone without titration. |
2020-09-29 |
2023-08-13 |
Not clear |
| G Martino, M Capasso, M Nasuti, L Bonanni, M Onofrj, A Thoma. Dopamine transporter single-photon emission computerized tomography supports diagnosis of akinetic crisis of parkinsonism and of neuroleptic malignant syndrome. Medicine. vol 94. issue 13. 2015-06-08. PMID:25837755. |
one was diagnosed as having nms because of exposure to risperidone. |
2015-06-08 |
2023-08-13 |
Not clear |
| Leticia González-Blanco, Hilario García-Prada, Susana Santamarina, Luis Jiménez-Treviño, Julio Bobe. Recurrence of neuroleptic malignant syndrome. Actas espanolas de psiquiatria. vol 41. issue 5. 2014-09-04. PMID:24096397. |
after its suspension and subsequent clinical recovery, antipsychotic treatment with risperidone was reintroduced and she suffered a recurrence of nms. |
2014-09-04 |
2023-08-12 |
Not clear |
| Praveen Tripathi, Hemika Agrawal, Priyanka Goyal, Sujita Kumar Ka. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution? Industrial psychiatry journal. vol 22. issue 2. 2014-07-11. PMID:25013321. |
it is commonly encountered with the use of first generation antipsychotics, however cases of nms have been reported with the use of second generation antipsychotics like olanzapine, risperidone, paliperidone, aripiprazole, ziprasidone, amisulpride, quetiapine and clozapine, though the incidence of such reports is rare. |
2014-07-11 |
2023-08-13 |
Not clear |
| Ali Ertug Arslankoylu, Meryem Ozlem Kutuk, Cetin Okuyaz, Fevziye Toro. Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus. Pediatric reports. vol 3. issue 3. 2011-11-10. PMID:22053263. |
here we report a child, with nms due to the risperidone misdiagnosed as status epilepticus. |
2011-11-10 |
2023-08-12 |
Not clear |
| D N Mendhekar, R C Jiloha, M M Mehndiratta, L Wa. Challenge with atypical antipsychotic drugs in risperidone induced neuroleptic malignant syndrome: a case report. Indian journal of psychiatry. vol 44. issue 4. 2011-07-14. PMID:21206609. |
there are several reports available on neuroleptic malignant syndrome (nms) associated with risperidone but when a more stringent criterion is applied there are only a few. |
2011-07-14 |
2023-08-12 |
Not clear |